Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache

ClinicalTrials.gov ID: NCT00033839

Public ClinicalTrials.gov record NCT00033839. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Evaluation of Civamide (Zucapsaicin) Nasal Solution in the Treatment of Episodic Cluster Headache

Study identification

NCT ID
NCT00033839
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Winston Laboratories
Industry
Enrollment
60 participants

Conditions and interventions

Interventions

  • Civamide (Zucapsaicin) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2001
Primary completion
Jun 30, 2003
Completion
Jun 30, 2003
Last update posted
Jun 9, 2011

2002 – 2003

United States locations

U.S. sites
26
U.S. states
19
U.S. cities
26
Facility City State ZIP Site status
Valley Neurological Headache & Research Center Phoenix Arizona 85020
Neurological Associates of Tucson Tucson Arizona 85712
Northern California Headache Clinic Mountain View California 94040
San Francisco Clinical Research Center San Francisco California 94109
California Medical Clinic for Headache Santa Monica California 90404
New England Center for Headache, PC Stamford Connecticut 06902
Neurology Clinical Research, Inc. Plantation Florida 33324
Neurology and Headache Specialists of Atlanta Decatur Georgia 30033
Diamond Headache Clinic Chicago Illinois 60614
Boston Clinical Research Center Wellesley Hills Massachusetts 02481
Michigan Headache Pain & Neurological Institute Ann Arbor Michigan 48104
Henry Ford Hospital Department of Neurology Detroit Michigan 48202
Department of Neurology Mayo Clinic Rochester Minnesota 55905
Mercy Health Research Chesterfield Missouri 63017
Headache Care Center/Clinvest Springfield Missouri 65804
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756
New York Headache Center New York New York 10021
The Headache Wellness Center Greensboro North Carolina 27401
Cincinnati Headache Clinic Cincinnati Ohio 45219
Cleveland Clinic Foundation Cleveland Ohio 44195
University of Oklahoma Oklahoma City Oklahoma 73104
Neurological Associates of Tulsa, Inc. Tulsa Oklahoma 74136
Jefferson Headache Center Philadelphia Pennsylvania 19107
Nashville Neuroscience Center Nashville Tennessee 37203
Houston Headache Clinic Houston Texas 77004
The Neurology and Headache Treatment Center (Innovative Clinical Research) Alexandria Virginia 22304

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00033839, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 9, 2011 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00033839 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →